52 filings
Page 2 of 3
8-K
w4pzxk
12 Jun 23
Regulation FD Disclosure
7:05am
8-K
0fhqp7
8 Jun 23
Entry into a Material Definitive Agreement
7:00am
8-K
k03p64j9
15 May 23
Entry into a Material Definitive Agreement
7:00am
8-K
i1qqy7s364kldolr76
20 Apr 23
Regulation FD Disclosure
7:05am
8-K
ynoib79y
5 Apr 23
Entry into a Material Definitive Agreement
4:30pm
8-K
0ct6hiizh0qtsketd
8 Mar 23
Entry into a Material Definitive Agreement
4:30pm
8-K
cp56beie60oh2wfz ck
21 Feb 23
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
7:05am
8-K
2ad2d3 ns5
16 Feb 23
Regulation FD Disclosure
7:05am
8-K
r1m7y
21 Dec 22
Regulation FD Disclosure
9:01am
8-K
919f8odn5nl3ww
16 Dec 22
Entry into a Material Definitive Agreement
6:14pm
8-K
d4rq5r
15 Dec 22
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) Clinical Trial Progress and Pre-clinical Research Developments
9:00am
8-K
qmtuf1 ovl
7 Dec 22
MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders
9:50pm
8-K
x87 o5jowch
2 Dec 22
Entry into a Material Definitive Agreement
4:55pm
8-K
w3u6b dxqumelgfphf
21 Nov 22
TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies
7:05am
8-K
098gcayt
14 Nov 22
Regulation FD Disclosure
4:32pm
8-K
nt380qs
14 Nov 22
TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation
7:05am
8-K
4hvaeq6ivy9j
1 Nov 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:01pm
8-K
cs73tmmu7jbul
26 May 22
Entry into a Material Definitive Agreement
4:52pm
8-K
wow8hxi4
10 Mar 22
MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination
8:00am
8-K
l4oz71x2
7 Mar 22
Departure of Directors or Certain Officers
5:44pm